Free Trial

DHT (DHT) Institutional Ownership

DHT logo
$17.95 +0.14 (+0.76%)
As of 02:39 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for DHT (NYSE:DHT)

Current
Institutional Ownership
Percentage
58.53%
Number of
Institutional Buyers
(last 12 months)
186
Total
Institutional Inflows
(last 12 months)
$293.05M
Number of
Institutional Sellers
(last 12 months)
99
Total
Institutional Outflows
(last 12 months)
$108.94M
Get DHT Insider Trade Alerts

Want to know when executives and insiders are buying or selling DHT stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

DHT Institutional Buying and Selling by Quarter

DHT Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Sei Investments Co.235,857$4.31M0.0%-10.4%0.146%
5/14/2026State of Wyoming37,323$682K0.1%-27.3%0.023%
5/13/2026Cetera Investment Advisers14,844$271K0.0%-24.9%0.009%
5/13/2026Measured Wealth Private Client Group LLC25,978$475K0.1%N/A0.016%
5/13/2026Impala Asset Management LLC50,000$914K0.4%N/A0.031%
5/13/2026First Trust Advisors LP269,986$4.93M0.0%+15.0%0.168%
5/8/2026 PNC Financial Services Group Inc.4,846$89K0.0%+32.0%0.003%
5/7/2026 Dimensional Fund Advisors LP10,343,906$188.98M0.0%-0.8%6.433%
5/6/2026 Assetmark Inc.6,467$118K0.0%+5,032.5%0.004%
5/6/2026 WIT Partners Advisory Pte. Ltd.282,600$5.16M1.5%N/A0.176%
5/5/2026 Bank of New York Mellon Corp361,824$6.61M0.0%-0.6%0.225%
5/5/2026 Gentry Private Wealth LLC30,442$556K0.3%-11.3%0.019%
5/5/2026 Sanctuary Advisors LLC56,715$1.04M0.0%N/A0.035%
5/4/2026 Empirical Financial Services LLC d.b.a. Empirical Wealth Management55,524$1.01M0.0%+15.1%0.035%
5/4/2026 Principal Financial Group Inc.244,432$4.47M0.0%+26.5%0.152%
5/2/2026 International Assets Investment Management LLC48,018$870K0.0%-10.5%0.030%
5/1/2026 Commonwealth of Pennsylvania Public School Empls Retrmt SYS64,914$1.19M0.0%N/A0.040%
5/1/2026 Fifth Third Bancorp5,088$93K0.0%-24.8%0.003%
5/1/2026 U S Global Investors Inc.20,765$379K0.0%N/A0.013%
4/30/2026 Hsbc Holdings PLC23,431$426K0.0%N/A0.015%
4/30/2026 Summit Securities Group LLC5,200$95K0.0%+246.7%0.003%
4/30/2026 Kestra Advisory Services LLC36,208$662K0.0%-16.5%0.023%
4/30/2026 Azzad Asset Management Inc. ADV15,100$276K0.0%N/A0.009%
4/28/2026 Dividend Assets Capital LLC42,413$775K0.2%+47.0%0.026%
4/27/2026 Oxbow Advisors LLC252,881$4.62M0.4%N/A0.157%
4/27/2026 Counterpoint Mutual Funds LLC229,694$4.20M0.6%+451.1%0.143%
4/27/2026 Y Intercept Hong Kong Ltd58,486$1.07M0.0%-54.1%0.036%
4/27/2026 Leonteq Securities AG2,735$50K0.0%-43.6%0.002%
4/25/2026 Strs Ohio19,400$354K0.0%-69.4%0.012%
4/24/2026 Acorn Financial Advisory Services Inc. ADV718,271$13.12M1.8%N/A0.447%
4/22/2026 Janney Montgomery Scott LLC61,232$1.12M0.0%+358.6%0.038%
4/22/2026 Sterling Capital Management LLC4,484$82K0.0%-89.7%0.003%
4/20/2026 Ritholtz Wealth Management17,014$311K0.0%-4.7%0.011%
4/16/2026 Baron Wealth Management LLC14,750$269K0.1%+4.2%0.009%
3/9/2026EMC Capital Management9,086$111K0.0%-15.0%0.006%
3/3/2026 Caitong International Asset Management Co. Ltd3,554$43K0.0%+568.0%0.002%
2/23/2026Virtu Financial LLC58,504$714K0.0%N/A0.036%
2/19/2026 Invesco Ltd.157,295$1.92M0.0%-21.7%0.098%
2/19/2026 Axxcess Wealth Management LLC30,226$369K0.0%N/A0.019%
2/19/2026Corient Private Wealth LLC24,031$285K0.0%+4.9%0.015%
NNVC FDA = New Momentum Wave! (Ad)

NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles at a time when no approved antiviral treatments exist and cases are resurging globally. Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, Mpox, and more - giving NNVC exposure to multiple large markets as Phase II trials advance.tc pixel

See why this FDA milestone could be a catalyst for NNVC
2/18/2026Mercer Global Advisors Inc. ADV18,025$220K0.0%+18.3%0.011%
2/18/2026Empowered Funds LLC729,649$8.91M0.1%+9.6%0.454%
2/18/2026XTX Topco Ltd64,401$786K0.0%-15.7%0.040%
2/18/2026Uniplan Investment Counsel Inc.57,138$698K0.2%-62.6%0.036%
2/18/2026Voloridge Investment Management LLC359,843$4.39M0.0%+214.3%0.224%
2/18/2026Tudor Investment Corp ET AL811,795$9.91M0.0%+183.6%0.505%
2/18/2026Susquehanna Fundamental Investments LLC51,356$627K0.0%-3.5%0.032%
2/18/2026Polymer Capital Management US LLC29,106$355K0.0%+125.8%0.018%
2/18/2026Quadrature Capital Ltd11,084$135K0.0%N/A0.007%
2/18/2026Millennium Management LLC214,495$2.62M0.0%+322.9%0.134%
2/18/2026Manatuck Hill Partners LLC175,000$2.14M0.7%N/A0.109%
2/18/2026Gotham Asset Management LLC157,878$1.93M0.0%+25.3%0.098%
2/18/2026Engineers Gate Manager LP236,213$2.88M0.0%+163.2%0.147%
2/18/2026Boothbay Fund Management LLC49,822$608K0.0%N/A0.031%
2/18/2026Bridgeway Capital Management LLC1,184,149$14.46M0.3%-4.1%0.737%
2/17/2026Schonfeld Strategic Advisors LLC88,259$1.08M0.0%N/A0.055%
2/17/2026AQR Capital Management LLC545,855$6.67M0.0%+42.6%0.340%
2/17/2026Cetera Investment Advisers19,755$241K0.0%+11.0%0.012%
2/17/2026Lazard Asset Management LLC443,328$5.41M0.0%-0.8%0.276%
2/17/2026Jain Global LLC16,928$207K0.0%+40.7%0.011%
2/17/2026TCW Group Inc.343,276$4.19M0.0%-10.3%0.214%
2/17/2026BTG Pactual Asset Management US LLC205,782$2.51M0.2%N/A0.128%
2/17/2026Jump Financial LLC34,095$416K0.0%N/A0.021%
2/17/2026Price T Rowe Associates Inc. MD76,466$934K0.0%+12.4%0.048%
2/17/2026Osaic Holdings Inc.32,449$396K0.0%-11.8%0.020%
2/17/2026 Harvey Capital Management Inc.202,950$2.48M0.5%+2.4%0.126%
2/17/2026Public Employees Retirement System of Ohio132,697$1.62M0.0%+3,692.4%0.083%
2/17/2026 Russell Investments Group Ltd.418,560$5.11M0.0%-10.6%0.261%
2/17/2026Lombard Odier Asset Management USA Corp12,147$148K0.0%-71.5%0.008%
2/17/2026State of Wisconsin Investment Board27,612$337K0.0%+8.2%0.017%
2/17/2026Captrust Financial Advisors18,677$228K0.0%+59.9%0.012%
2/17/2026Royal Bank of Canada81,025$989K0.0%+291.6%0.050%
2/17/2026Mangrove Partners IM LLC17,367$212K0.0%N/A0.011%
2/16/2026Squarepoint Ops LLC87,203$1.07M0.0%+25.7%0.054%
2/16/2026Verition Fund Management LLC51,400$628K0.0%-5.7%0.032%
2/16/2026Mariner LLC388,516$4.74M0.0%+4.0%0.242%
2/16/2026Marnell Management LLC146,793$1.79M0.9%N/A0.091%
2/16/2026Healthcare of Ontario Pension Plan Trust Fund99,166$1.21M0.0%N/A0.062%
2/16/2026Barclays PLC256,544$3.13M0.0%+10.4%0.160%
2/13/2026 Kestra Advisory Services LLC43,348$529K0.0%-16.0%0.027%
2/13/2026The Manufacturers Life Insurance Company 88,752$1.08M0.0%+15.0%0.055%
2/13/2026Segall Bryant & Hamill LLC92,250$1.13M0.0%N/A0.057%
2/13/2026 Stifel Financial Corp14,828$181K0.0%-6.9%0.009%
2/13/2026Quarry LP2,209$27K0.0%-46.2%0.001%
2/13/2026Smartleaf Asset Management LLC11,794$143K0.0%+1,533.5%0.007%
2/13/2026Jacobs Levy Equity Management Inc.731,103$8.93M0.0%N/A0.455%
2/13/2026Public Sector Pension Investment Board744,601$9.09M0.0%+447.5%0.464%
2/13/2026First Trust Advisors LP234,853$2.87M0.0%+27.4%0.146%
2/13/2026Charles Schwab Investment Management Inc.336,991$4.12M0.0%+5.7%0.210%
2/13/2026State Street Corp2,269,460$27.71M0.0%+0.8%1.413%
NNVC FDA = New Momentum Wave! (Ad)

NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles at a time when no approved antiviral treatments exist and cases are resurging globally. Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, Mpox, and more - giving NNVC exposure to multiple large markets as Phase II trials advance.tc pixel

See why this FDA milestone could be a catalyst for NNVC
2/13/2026Van ECK Associates Corp346,233$4.23M0.0%N/A0.216%
2/13/2026Victory Capital Management Inc.3,008,679$36.74M0.0%+1.5%1.873%
2/13/2026Ieq Capital LLC114,527$1.40M0.0%+27.2%0.071%
2/13/2026 Boston Partners235,451$2.88M0.0%-9.6%0.147%
2/13/2026Martingale Asset Management L P211,965$2.59M0.1%+29.7%0.132%
2/13/2026Dynamic Technology Lab Private Ltd23,644$289K0.1%-42.8%0.015%
2/13/2026 Wells Fargo & Company MN169,596$2.07M0.0%+45.3%0.106%
2/13/2026Summit Financial LLC119,438$1.46M0.0%+0.9%0.074%
2/12/2026 Wasatch Advisors LP2,127,983$25.98M0.2%-8.6%1.325%
2/12/2026 Rossby Financial LCC26,000$317K0.1%+7.9%0.016%


DHT Institutional Ownership - Frequently Asked Questions

During the previous two years, 286 institutional investors and hedge funds held shares of DHT. The most heavily invested institutionals were FMR LLC ($224.81M), Dimensional Fund Advisors LP ($188.98M), American Century Companies Inc. ($63.10M), DME Capital Management LP ($48.74M), Hosking Partners LLP ($43.87M), Acadian Asset Management LLC ($39.18M), and Victory Capital Management Inc. ($36.74M).Learn more on DHT's institutional investors.

58.53% of DHT's stock is owned by institutional investors. Learn more on DHT's institutional investor holdings.

Of the 250 institutional investors that purchased DHT's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wasatch Advisors LP ($5.33M), Victory Capital Management Inc. ($2.87M), American Century Companies Inc. ($2.57M), FMR LLC ($2.20M), Encompass Capital Advisors LLC ($1.90M), Qube Research & Technologies Ltd ($1.60M), and Bridgeway Capital Management LLC ($1.24M).

Institutional investors have bought a total of 24,197,660 shares in the last 24 months. This purchase volume represents approximately $293.05M in transactions.

Of the 97 institutional investors that sold DHT's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Wasatch Advisors LP ($2.42M), MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. ($1.02M), Tudor Investment Corp ET AL ($617.25K), Goldman Sachs Group Inc. ($530.08K), Renaissance Technologies LLC ($495.65K), UBS Group AG ($311.46K), and JPMorgan Chase & Co. ($305.26K).

Institutional investors have sold a total of 9,360,186 shares in the last 24 months. This volume of shares sold represents approximately $108.94M in transactions.



This page (NYSE:DHT) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners